Former U.S. Secretary of Defense James Mattis, former U.S. Secretary of State Henry Kissinger, and media titan Ruport Murdoch could all be called to testify.
Federal prosecutors plan to expand the scope of the case with a 2nd superseding indictment.
U.S. District Judge Edward Davila on Monday said "we're guided by the cloud of Covid" in thinking about pushing back the start of the trial, which was scheduled to begin in October. Davila, who was hesitant about delaying the trial said "to take the foot off the gas pedal makes the finish line more obscured."Prosecutors allege Holmes and her co-defendant, former Theranos President Sunny Balwani, knowingly deceived investors, business partners and doctors, despite promising they could run hundreds of lab tests with just a drop or two of blood.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oxford Coronavirus Vaccine 'Safe' And Showing 'Promising Results'A clinical trial of the vaccine against COVID-19 found it induces an immune reaction.
Read more »
California Officially Says No High School Football Until January Due to COVID-19It's official ... no high school football in 2020 in California -- the season will now begin in January and could pose some serious issues for multi-sport athletes.
Read more »
'Tenet' release delayed again by Warner Bros. amid COVID-19 spikesThe Burbank studio did not set a new release date for the Christopher Nolan film, which had already been pushed back twice due to theater closures.
Read more »
First human trial of AstraZeneca COVID-19 vaccine shows promiseAstraZeneca&39;s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain&39;s University of Oxford, did not prompt any
Read more »
British pharma firm claims small trial on a coronavirus treatment could signal 'major breakthrough'British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.
Read more »
Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stageAt least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a more durable form...
Read more »